The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy ...
Add Yahoo as a preferred source to see more of our stories on Google. The thrombectomy devices market will grow significantly Acute ischaemic stroke cases are expected to rise from around seven ...
E2 raises $80M to scale Hēlo®, improving pulmonary embolism treatment with faster, safer, and more efficient procedures.
InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful completion of 30 cases using the Recana(R) Thrombectomy ...
Surmodics, Inc. SRDX recently announced the successful early clinical use of the company’s Pounce LP (Low Profile) Thrombectomy System. With the addition of a low-profile device, the Surmodics Pounce ...
ClotHound ACE Gold PE and ClotHound ACE Blue DVT Thrombectomy Systems: Innovations in Vascular Care. New Study Confirms Promising Results of Innovative Thrombectomy Device in Porcine Model, Marking a ...
Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were ...
Long Beach, Calif. – May 3, 2024 – Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The ...
Please provide your email address to receive an email when new articles are posted on . Two new thrombectomy devices showed good safety and efficacy in the treatment of intermediate-risk pulmonary ...
With the addition of the Pounce™ XL Thrombectomy System, indicated for use in 5.5–10 mm peripheral arteries, the fully mechanical Pounce™ Thrombectomy Platform can now remove thrombi or emboli ...
YOKNEAM, Israel & DALLAS--(BUSINESS WIRE)--Rapid Medical™, a leading developer of advanced neurovascular devices, announces the first successful robotic thrombectomy in Medellín, Colombia. Two ...
InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results